Valpros: For the treatment of generalized, partial or other epilepsy.
For the treatment and prevention of mania associated with bipolar disorders.
Valpros i-IV: Sodium valproate is indicated as an intravenous (IV) alternative in patients for whom oral administration of valproate products is temporarily not feasible in the following conditions: Monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures; Monotherapy and adjunctive therapy in the treatment of patients with simple and complex absence seizures, and adjunctively in patients with multiple seizure types that include absence seizures.
Other Services
Country
Account